KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Gross Margin (2016 - 2025)

LifeMD (LFMD) has disclosed Gross Margin for 14 consecutive years, with 40.22% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 5972.0% year-over-year to 40.22%, compared with a TTM value of 71.85% through Dec 2025, down 1430.0%, and an annual FY2025 reading of 85.72%, down 43.0% over the prior year.
  • Gross Margin was 40.22% for Q4 2025 at LifeMD, down from 85.84% in the prior quarter.
  • Across five years, Gross Margin topped out at 92.95% in Q3 2024 and bottomed at 19.5% in Q4 2024.
  • Average Gross Margin over 5 years is 76.47%, with a median of 84.88% recorded in 2022.
  • The sharpest move saw Gross Margin plummeted -10756bps in 2024, then surged 5972bps in 2025.
  • Year by year, Gross Margin stood at 79.69% in 2021, then increased by 7bps to 85.53% in 2022, then increased by 3bps to 88.06% in 2023, then tumbled by -122bps to 19.5% in 2024, then soared by 306bps to 40.22% in 2025.
  • Business Quant data shows Gross Margin for LFMD at 40.22% in Q4 2025, 85.84% in Q3 2025, and 55.56% in Q2 2025.